Pfizer and BioNTech announced Friday that their vaccine can be stored at higher than the ultra-low temperatures they had previously specified.
The companies announced they have submitted new data to the U.S. Food and Drug Administration (FDA) that shows the COVID-19 vaccine can be stored at -25 to -15 degrees Celsius (-13 to 5 degrees Fahrenheit), proposing a new update to the Emergency Use Authorization (EUA) prescribing information.